Inventor

BUYSE MARIE-ANGE

BE59 patents

⚠️ This page may combine multiple inventors who share the name “BUYSE MARIE-ANGE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BUYSE MARIE-ANGE

ABLYNX NV

Immunoglobulin variable domains

Immunoglobulin variable domains

Immunoglobulin variable domains

Immunoglobulin variable domains

Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains

TNF binders

Immunoglobulin variable domains

Immunoglobulin variable domains

Serum albumin binders

Immunoglobulin variable domains

Serum albumin-binding immunoglobulin variable domains

Polypeptides against IL-23

Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies

TNF binders

Serum albumin binding proteins containing immunoglobulin single variable domains

Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains

Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains

Immunoglobulin variable domains

Nucleic acids encoding polypeptides against IL-23

Glycosylated immunoglobulin single variable domains

Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains

Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains

Polypeptides inhibiting CD40L

Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies

Immunoglobulin variable domains

INNOGENETICS NV

Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders

Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use

Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use

Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue

Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use

Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use

Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders

MERCK SHARP & DOHME

PD1/CTLA4 binders

CTLA4 binders

PD1 and/or LAG3 binders

PD1 and/or LAG3 binders

PD1 and/or LAG3 binders

PD1 and/or LAG3 binders

BOEHRINGER INGELHEIM INT

Biparatopic polypeptides antagonizing Wnt signaling in tumor cells

Polypeptides antagonizing Wnt signaling in tumor cells

Biparatopic polypeptides antagonizing Wnt signaling in tumor cells

Bispecific binding molecules binding to VEGF and Ang2

Bispecific binding molecules binding to VEGF and Ang2

ROCHE DIAGNOSTICS GMBH

Method for simultaneous detection of HIV antigens and HIV antibodies

GSCHWIND ANDREAS

Bispecific binding molecules binding to VEGF and ANG2

NOVARTIS AG

Chemokine receptor binding polypeptides

BUYSE MARIE-ANGE

HPV polyepitope constructs and uses thereof

MERCK PATENT GMBH

ADAMTS binding immunoglobulins

NOVO NORDISK AS

Factor X binders enhancing FX activation

MERCK SHARP & DOHME LLC

PD1 and/or LAG3 binders